I use the USAToday as a bellweather for public information.  By the time they get a story out, it should be in the public conciousness.

 

 

Take a look at the companies that are attracting attention.  These are the ones with sales.  These are the ones with revenue, and could either blow things out with the protection of a major biotech, or an infusion of capital via the public markets.

 

The ones that are long term research, well they're going to have trouble.

 

Lots of trouble.